X0202 SCHEDULE 13G/A 0002131234-26-000001 0002131234 XXXXXXXX LIVE 1 Common Stock, par value $0.01 per share 06/30/2026 0000911216 PALATIN TECHNOLOGIES INC 696077601 301 Carnegie Center Drive Suite 304 Princeton NJ 08540 Rule 13d-1(b) AuGC BioFund LP DE 0.00 84000.00 0.00 84000.00 84000.00 4.7 PN AuGC Partners LLC DE 0.00 84000.00 0.00 84000.00 84000.00 4.7 IA HC OO Evan Markegard X1 0.00 84000.00 0.00 84000.00 84000.00 4.7 HC IN PALATIN TECHNOLOGIES INC 301 Carnegie Center Drive, Suite 304, Princeton, NEW JERSEY, 08540. AuGC BioFund LP AuGC Partners LLC Evan Markegard AuGC BioFund LP c/o AuGC Partners LLC 10875 Kemah Lane San Diego, CA 92131 AuGC Partners LLC 10875 Kemah Lane San Diego, CA 92131 Evan Markegard c/o AuGC Partners LLC 10875 Kemah Lane San Diego, CA 92131 AuGC BioFund LP - Delaware AuGC Partners LLC - Delaware Evan Markegard - United States N IA HC AuGC Partners LLC is an investment adviser that is registered as an Exempt Reporting Adviser with the Securities and Exchange Commission. AuGC Partners LLC, which serves as investment adviser to AuGC BioFund LP (the "Fund"), may be deemed to be the beneficial owner of all shares of Common Stock held by the Fund. Mr. Markegard, as Managing Member of AuGC Partners LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owner of all shares of Common Stock held by the Fund. Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, AuGC Partners LLC and Mr. Markegard expressly disclaim beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that AuGC Partners LLC or Mr. Markegard are the beneficial owner of any of the securities reported herein. AuGC BioFund LP - 84,000 AuGC Partners LLC - 84,000 Evan Markegard - 84,000 Ownership percentage is based on 1,779,275 shares of common stock outstanding, par value $0.01 per share, as of May 12, 2026, as reported by the Issuer on Form 10-Q filed with the Securities and Exchange Commission on May 13, 2026. AuGC BioFund LP - 4.7% AuGC Partners LLC - 4.7% Evan Markegard - 4.7% AuGC BioFund LP - 0 AuGC Partners LLC - 0 Evan Markegard - 0 AuGC BioFund LP - 84,000 AuGC Partners LLC - 84,000 Evan Markegard - 84,000 AuGC BioFund LP - 0 AuGC Partners LLC - 0 Evan Markegard - 0 AuGC BioFund LP - 84,000 AuGC Partners LLC - 84,000 Evan Markegard - 84,000 Y Y N See Notes above. Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. AuGC BioFund LP /s/ Evan Markegard 08/14/2026 AuGC Partners LLC /s/ Evan Markegard 08/14/2026 Evan Markegard /s/ Evan Markegard 08/14/2026